In summary, health benefits and improved quality of life are realized when patients being treated for chronic conditions are monitored closely. With the direct correlation between metformin use and potential consequences established, the frequency and extent of vitamin B12 screening needs to be addressed.5

Substantial support exists for monitoring at-risk patients, especially those presenting with complaints of neuropathy. It is important to educate providers and patients of this risk, monitor for symptoms of neuropathy, assess vitamin B12 levels when deemed appropriate, and consider prophylaxis when metformin is initially prescribed to thwart the development of symptoms.

Implementation of a simple routine laboratory screening test in conjunction with oral or injectable supplementation of vitamin B12 would reduce the risk for metformin-induced vitamin B12 deficiency. Such shifts in the treatment paradigm would allow patients to follow a continuum of health and minimize the deleterious effects of T2DM, such as physical inactivity because of peripheral neuropathy, weight gain, depression, and poor glucose control. Proactively addressing the risk of developing low vitamin B12 levels in this patient population not only reduces potential physical and mental sequelae but also lessens the financial burden of disease, appointments, testing, loss of time from work, and reduction in wages. Efficient patient care, coupled with prudent expenditure of healthcare dollars, benefits all stakeholders, and screening and supplementation of vitamin B12 in this patient population is one example of such care.

Paula Peacock, ARNP, FNP-BC, MSN, is a nurse practitioner at Baptist Health, in Jacksonville, Florida.

Follow @EndoAdvisor


1. Agarwal P, Mital P, Meena VK, Mital P, Nawal CL, Goyal LK. A comparative study of levels of vitamin B12 in patients of type 2 diabetes mellitus on metformin and not on metformin at tertiary care center. Int J Adv Med. 2016;3(3):759-763.

2. Aroda VR, Edelstein SL, Goldberg RB, et al; Diabetes Prevention Program Research Group. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761.

3. Chapman LE, Darling AL, Brown JE. The association between the biguanide drug metformin and vitamin B12 deficiency in diabetic patients: a systematic review. Presented at: Nutrition Society Summer Meeting; July 2014; Glasgow, Scotland.

4. Damião CP, Rodrigues AO, Pinheiro MF, et al. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study. Sao Paulo Med J. 2016;134(6):473-479.

5. Ghefreh A. Metformin and vitamin B12 deficiency. Accessed March 27, 2019.

6. Kancherla V, Garn JV, Zakai NA, et al. Multivitamin use and serum vitamin B12 concentrations in older-adult metformin users in REGARDS, 2003-2007. PLoS One. 2016;11(8):e0160802.

7. Ko SH, Ko SH, Ahn YB, et al. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J Korean Med Sci. 2014;29(7):965-972.

8. Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified? J Diabetes Metab Disord. 2013;12(1):17.

9. Kos E, Liszek MJ, Emanuele MA, Durazo-Arvizu R, Camacho P. Effect of metformin therapy on vitamin D and vitamin B12 levels in patients with type 2 diabetes mellitus. Endocr Pract. 2012;18(2):179-184.

10. Mazokopakis EE, Starakis, IK. Recommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiency. Diabetes Res Clin Pract. 2012;97(3):359-367.

11. Niafar M1, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med. 2015;10(1):93-102.

12. Osama H, Hussein HAE, Abdelrahim MEA, Salem HF.  Screening the effect of metformin on serum vitamin B12 and blood homocysteine levels in patients with type 2 diabetes mellitus. Med-Science. 2016;5(1):46-56.

13. Quereshi SA, Ainsworth A, Winocour PH. Metformin therapy and assessment for vitamin B12 deficiency: is it necessary? Pract Diabetes. 2011;28(7):302-304

14. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B₁₂ deficiency with metformin therapy and vitamin B₁₂ supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2012;35(2):327-333.

15. Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr J. 2013;60(12):1275-1280.

16. Singh A, Kumar A, Karmakar D, Jha R. Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2013;59(4):253-257.

17. Xu L, Huang Z, He X, Wan X, Fang D, Li Y. Adverse effect of metformin therapy on serum vitamin B12 and folate: short-term treatment causes disadvantages? Med Hypotheses. 2013;81(2):149-151.  

18. Raizada N, Jyotsna VP, Sreenivas V, Tandon N. Serum vitamin B12 in type 2 diabetic patients on metformin compared to those never on metformin: a cross-sectional study.  Indian J Endocrinol Metab. 2017;21(3):424-428.

19. Caspary WF, Zavada I, Reimold W, Deuticke E, Emrich D, Willms B. Alteration of bile acid metabolism and vitamin-B12-absorption in diabetics on biguanides. Diabetologia. 1977;13(3):187-193.

20. Audhya T. Role of B vitamin in biological methylation. Health Diagnostics and Research Institute. 2012;1-19.

21. Jeetendra S, Tushar B. Metformin use and vitamin B12 deficiency in patients with type-2 diabetes mellitus. MVP J Med Sci. 2016;3(1):67-70.

22. Garber AJ, Abrahamson MJ, Barzilay JI. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm – 2018 executive summary. Endocr Pract. 2018; 24(1):91-120.

23. Vitamin B12 Blood Test. RequestATest website. Accessed March 21, 2019.

24. Vitamin B12 1000 mcg. website. Accessed March 21, 2019.

25. Cyanocobalamin. GoodRx website. Accessed March 21, 2019.

26. website. Accessed March 27, 2019.

27. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the U.S. Diabetes Care, 2003;26(6):1790-1795.

28. Koski RR, Rider-Becker JM.  Managing the cost of chronic diabetic peripheral neuropathy in the elderly. US Pharm. 2009;34(1):30-38.

29. Holt C. Should people treated with metformin be screened for vitamin B12 deficiency? Diabetes & Primary Care. 2012;14(4):204-212.  

This article originally appeared on Clinical Advisor